ASPEYA Trademark

Trademark Overview


On Monday, September 23, 2024, a trademark application was filed for ASPEYA with the United States Patent and Trademark Office. The USPTO has given the ASPEYA trademark a serial number of 98764745. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, June 27, 2025. This trademark is owned by Vectura Fertin Pharma Switzerland S.A.. The ASPEYA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations,anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyr...

Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals

Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty

Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems
aspeya

General Information


Serial Number98764745
Word MarkASPEYA
Filing DateMonday, September 23, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, June 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations,anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nutraceuticals for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions; pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum for use as an aid to stop smoking
Goods and ServicesMedical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals
Goods and ServicesMedical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty
Goods and ServicesMedical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, September 23, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 23, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameASPEYA SWITZERLAND SA
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressLAUSANNE 1007
CH

Party NameVectura Fertin Pharma Switzerland S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLausanne 1007
CH

Trademark Events


Event DateEvent Description
Monday, September 23, 2024NEW APPLICATION ENTERED
Wednesday, December 4, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, December 4, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 29, 2025ASSIGNED TO EXAMINER
Saturday, March 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 29, 2025NON-FINAL ACTION WRITTEN
Saturday, March 29, 2025NON-FINAL ACTION E-MAILED
Friday, April 11, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED